INKA2-AS1 Is a Potential Promising Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma

Table 1

Correlation of INKA2-AS1 expression with clinicopathological features of HCC.

Characteristic	Low expression of INKA2-AS1	High expression of INKA2-AS1
	187	187
Age (, %)			0.874
≤60	90 (24.1%)	87 (23.3%)
>60	97 (26%)	99 (26.5%)
Gender (, %)			0.015
Female	49 (13.1%)	72 (19.3%)
Male	138 (36.9%)	115 (30.7%)
Histologic grade (, %)			0.036
G1	36 (9.8%)	19 (5.1%)
G2	91 (24.7%)	87 (23.6%)
G3	52 (14.1%)	72 (19.5%)
G4	6 (1.6%)	6 (1.6%)
Vascular invasion (, %)			0.217
No	113 (35.5%)	95 (29.9%)
Yes	51 (16%)	59 (18.6%)
Residual tumor (, %)			0.220
R0	168 (48.7%)	159 (46.1%)
R1	6 (1.7%)	11 (3.2%)
R2	1 (0.3%)	0 (0%)
Pathologic stage (, %)			0.023
Stage I	100 (28.6%)	73 (20.9%)
Stage II	37 (10.6%)	50 (14.3%)
Stage III	35 (10%)	50 (14.3%)
Stage IV	2 (0.6%)	3 (0.9%)
T stage (, %)			0.030
T1	105 (28.3%)	78 (21%)
T2	39 (10.5%)	56 (15.1%)
T3	35 (9.4%)	45 (12.1%)
T4	5 (1.3%)	8 (2.2%)
M stage (, %)			1.000
M0	133 (48.9%)	135 (49.6%)
M1	2 (0.7%)	2 (0.7%)
N stage (, %)			0.122
N0	129 (50%)	125 (48.4%)
N1	0 (0%)	4 (1.6%)
Age (median, IQR)	61 (52, 69)	62 (51, 68)	0.492